title: Reshaping the future of nanopharmaceuticals: ad iudicium.
abstract: We present views on the future development of biologics-based nanopharmaceuticals from a "high risk-high gain" perspective and within the context of personalized therapies. Integrated scientific, commercial, and societal aspects are addressed, and provocative combined realistic biotech, computational, and nanotech approaches for tailor-made engineering of nanopharmaceuticals are discussed.
authors: Centre for Pharmaceutical Nanotechnology and Nanotoxicology, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen Ø, Denmark. momo@farma.ku.dk
authors: S Moein
authors: SM
authors: Moghimi
authors: Dan
authors: D
authors: Peer
authors: Robert
authors: R
authors: Langer
mesh_terms: D001695:Biology; D055808:Drug Discovery / Q000191:economics / Q000639:trends*; D006801:Humans; D050997:Nanomedicine / Q000191:economics / Q000639:trends*; D057285:Precision Medicine; D012306:Risk